Authors: Vicki Taasti1, Nils Peters2, Alessandra Bolsi3, Christina Vallhagen Dahlgren4, Malte Ellerbrock5, Carles Gomà6, Joanna Góra7, Patricia Cambraia Lopes8, Ilaria Rinaldi9, Koen Salvo10, Ivanka Sojat Tarp11, Alessandro Vai12, Thomas Bortfeld13, Antony Lomax14, Christian Richter2, Patrick Wohlfahrt13
1Department of Radiation Oncology (MAASTRO), GROW – School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands; 2OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 3Paul Scherrer Institute, Center for Proton Therapy, Villigen, Switzerland; 4The Skandion Clinic, Department of Medical Physics, Uppsala, Sweden; 5Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; 6Department of Radiation Oncology, Hospital Clínic de Barcelona, Barcelona, Spain; 7EBG MedAustron GmbH, Division of Medical Physics, Wiener Neustadt, Austria; 8Holland Proton Therapy Center, Department of Medical Physics, Delft, The Netherlands; 9Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands; 10Algemeen Ziekenhuis Sint-Maarten, Department of Radiotherapy, Duffel, Belgium; 11Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; 12Radiotherapy Department, Center for National Oncological Hadrontherapy (CNAO), Pavia, Italy; 13Massachusetts General Hospital and Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA; 14Center for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland